MLD patients exhibit augmented levels of pro-inflammatory cytokines and chemokines including CCL2, IL-1Ra, IL-8, and CCL4 in the cerebral spinal fluid. The gene discussed is CCL4; the disease is metachromatic leukodystrophy.